Cargando…

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine

The humanization of animals is a powerful tool for the exploration of human disease pathogenesis in biomedical research, as well as for the development of therapeutic interventions with enhanced translational potential. Humanized models enable us to overcome biologic differences that exist between h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adigbli, George, Ménoret, Séverine, Cross, Amy R., Hester, Joanna, Issa, Fadi, Anegon, Ignacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590965/ https://www.ncbi.nlm.nih.gov/pubmed/32068660 http://dx.doi.org/10.1097/TP.0000000000003177

Ejemplares similares

Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8(+)regulatory T cells-mediated long-term graft survival
por: Bézie, Séverine, et al.
Publicado: (2011)

In Vivo Analysis of Human Immune Responses in Immunodeficient Rats
por: Ménoret, Séverine, et al.
Publicado: (2020)

Tranilast, an analogue of tryptophan catabolites, induces allograft tolerance by CD161(+) cells
por: Ménoret, Séverine, et al.
Publicado: (2011)

Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo
por: Adigbli, George, et al.
Publicado: (2021)

Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
por: Chenouard, Vanessa, et al.
Publicado: (2021)

Recent advances in our understanding of the allograft response
por: Hennessy, Conor, et al.
Publicado: (2021)

Transgenesis and genome analysis, Nantes, France, June 6th 2011
por: Ménoret, Séverine, et al.
Publicado: (2011)

Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function
por: Rannou, Alice, et al.
Publicado: (2020)

IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
por: Kawai, Kento, et al.
Publicado: (2021)

Fibrinogen-Like Protein 2/Fibroleukin Induces Long-Term Allograft Survival in a Rat Model through Regulatory B Cells
por: Bézie, Séverine, et al.
Publicado: (2015)

Graft-versus-host disease after liver transplantation
por: Chaib, Eleazar, et al.
Publicado: (2011)

Graft-versus-host disease after kidney transplantation
por: Kim, Jong Man, et al.
Publicado: (2011)

Graft-Versus-Host Disease After Pancreatic Transplantation
por: Saffo, Saad, et al.
Publicado: (2019)

Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency?
por: Flinn, Aisling M., et al.
Publicado: (2017)

Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021)

Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines
por: Iqbal, Muhammad Arsalan, et al.
Publicado: (2019)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection
por: Bézie, Séverine, et al.
Publicado: (2020)

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Stark, Helen L., et al.
Publicado: (2021)

Acute graft versus host disease after orthotopic liver transplantation
por: Rogulj, Inga Mandac, et al.
Publicado: (2012)

Graft-versus-Host Disease after Living-Unrelated Kidney Transplantation
por: Zacharias, N., et al.
Publicado: (2014)

“Phage Transplantation in Allotransplantation”: Possible Treatment in Graft-Versus-Host Disease?
por: Górski, Andrzej, et al.
Publicado: (2018)

Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation
por: Ilyas, Muneeb, et al.
Publicado: (2017)

Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
por: Shouval, Roni, et al.
Publicado: (2019)

Acute graft-versus-host disease after double lung transplantation
por: Kim, Nicole, et al.
Publicado: (2021)

Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients
por: Kim, Edward, et al.
Publicado: (2021)

Graft-versus-host disease after simultaneous pancreas-kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Acute Graft Versus Host Disease After Kidney-Pancreas Transplant
por: Lopez, James, et al.
Publicado: (2023)

Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats
por: Jung, Chris J., et al.
Publicado: (2016)

The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models
por: Teshima, Takanori, et al.
Publicado: (2021)

Graft versus host disease following liver transplantation: A case report
por: ZHANG, CHANGSONG, et al.
Publicado: (2014)

The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
por: Biliński, Jarosław, et al.
Publicado: (2022)

Graft versus host disease after liver transplantation: A case report
por: Acar, Sencan, et al.
Publicado: (2022)

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
por: Kim, Hyun Min, et al.
Publicado: (2023)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
por: Ardizzoia, Federica, et al.
Publicado: (2022)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Ibrahim, Uroosa, et al.
Publicado: (2021)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jsmcc647egvufdtovur84nqnkd